1. Introduction
===============

*Helicobacter pylori* is the most important etiological agent of chronic gastritis and peptic ulcer and it is also known to increase the risk of gastric cancer [@B1]-[@B4]. The Mongolian gerbil is a useful animal model to investigate human gastric disorders: *H. pylori* easily infects the stomach of Mongolian gerbils, thereby inducing human-mimicking gastritis, peptic ulcer and intestinal metaplasia in the stomach. In addition, this animal model can develop gastric adenocarcinoma by inoculation of *H. pylori* [@B5].

Accumulating evidence has demonstrated that the eradication of *H. pylori* in the stomachs by the administration of oral antimicrobial agents results in the resolution of *H. pylori*-associated gastroduodenal diseases [@B6]-[@B8]. In addition, the eradication of *H. pylori* is also reported to decrease the risk of gastric carcinogenesis in Mongolian gerbils [@B9], [@B10]. Triple combination therapy, using two antibacterial antibiotics and a proton pump inhibitor, achieved a high eradication rate [@B11]-[@B13]. However, such combination therapy does not always successfully eradicate *H. pylori*. In recent years, the increased occurrence of clarithromycin- and/or metronidazole-resistant strains of *H. pylori* has become a problem [@B14], [@B15]. In addition, antibiotics cannot be used due to drug allergies in some patients and the antibiotic therapy is also occasionally associated with adverse events. Furthermore, it is considered to be inappropriate to administer antimicrobial agents long-term to prevent *H. pylori* infection. Consequently, it is important to investigate the use of non-antibiotic therapies for *H. pylori* infection, which are highly effective and safe.

Many investigators have researched non-antibiotic therapies for *H. pylori* infection [@B16]-[@B21], utilizing plant extracts and constituents, probiotics, antioxidants, and so on. However, regarding rice-extract, no studies have yet been reported except ours [@B22]. In our previous study using an animal model, a Rice Power Extract (RPE) showed a suppressive effect on gastric mucosal inflammation, but it did not show any significant decrease in the viable *H. pylori* obtained from stomach samples [@B22]. This time, we employed a different type of rice extract, Japanese-Rice-Fluid (JRF, patent number 3655880). The JRF has already been reported to show a strong *in vitro* bactericidal activity against *H. pylori* [@B23] and there were no resistant strains of *H. pylori* [@B23]. In addition, it is easily manufactured and has recently been adopted as an ingredient in several kinds of liquid food as the main supplemental ingredient, and it is commercially available all over Japan.

In this study, we investigated the antibiotic effect of JRF on *H. pylori* infection *in vivo* and its anti-inflammatory effects on the *H. pylori*-induced gastritis, using a Mongolian gerbil model.

2. Materials and Methods
========================

Animals
-------

Specific pathogen-free male Mongolian gerbils (*Meriones unguiculatus*) (MGS/Sea) (Seac Yoshitomi, Ltd., Fukuoka, JAPAN), 7 weeks old, were housed in plastic cages with hard wood chips in an air-conditioned biohazard room for infection with a 12 hours light-12 hours dark cycle. They were given food (CE-2, Clea Japan Inc., Tokyo, Japan) and water or the JRF as drinking water in bottles *ad libitum*. Approval for this study was obtained prior to experimentation from the animal ethics committee, and all procedures were performed in compliance with Guidelines for the Care and Use of Laboratory Animals in Shinshu University.

Bacterial inoculation
---------------------

*H. pylori* (ATCC43504, CagA+, VacA+, American Type Culture Collection, Rockville, MD, USA) was grown in Brucella broth (Becton Dickinson, Cockeysville, MD, USA) containing 10 % v/v horse serum at 37 °C under microaerophilic conditions (15% CO~2~) at high humidity for 40 hours with gentle shaking (150 rpm). After each gerbil had fasted for 24 hours, samples containing 1x 10^9^ colony-forming units (CFU) per milliliter (0.8 ml) were used as the inoculum, which were delivered via an oral catheter.

Chemicals
---------

The production of the Japanese rice-fluid (JRF) was conducted in 5 phases (patent number 3655880). Phase 1 involved the addition of 15-times volume of distilled water to polished Japanese raw rice. Phase 2 involved their incubation at 128 °C under pressure of 0.1 to 0.5 Mpa for 5 min. In phase 3, they were completed mixed by homogenizing, and then were cooled down to 40 to 55 °C. In phase 4, they were treated for 15 to 30 min. with the addition of some proteinase and amylase complexes, including alpha-amylase, beta-amylase, and gluco-amylase. In the last phase 5, the added enzymes were inactivated by heating the mixture up to 95 °C. Based on our preliminary experiment, the JRF containing 25% saccharides was used in this study. The JRF also contains 1 % protein, but no lipid.

Experimental protocol
---------------------

Fifty gerbils were divided into 4 groups. Group A comprised 20 gerbils that were inoculated with *H. pylori* at 7 weeks of age and given JRF as drinking water in bottle ad libitum from 2 weeks until 14 weeks after *H. pylori*inoculation. Group B comprised 19 gerbils that were inoculated with *H. pylori* and given autoclaved distilled water. Group C (6 gerbils) and D (5 gerbils) were not inoculated with *H. pylori*; Group C was given JRF and Group D was given distilled water. Following a 24-h fasting period, with free access to drinking water without JRF, the gerbils were sacrificed. All gerbils were sacrificed under deep ether anesthesia at 21 weeks of age and then their stomachs were excised. Thirty minutes before being sacrificed, the gerbils were given 5\'-bromo-2\'deoxyuridine (BrdU) intraperitoneally at a dose of 200 mg/Kg. The excised stomachs were cut open along the greater curvature and then were divided in half along the lesser curvature. One half was used for a culture study while the other was used for histopathological analyses. (Fig. [1](#F1){ref-type="fig"})

Bacterial cultures
------------------

The excised stomachs (half) were homogenized with 5 ml of Brucella broth and then the resulting samples were diluted serially, from 1:10 to 1:1000000, with Brucella broth for the culture of *H. pylori*. Aliquots (100 ul) of the dilutions were inoculated on to *H. pylori* agar plates (Nissui Pharmaceutical Co, Tokyo, Japan). All plates were incubated at 35 °C for 7 days under microaerophilic conditions and high humidity. The density of *H. pylori* was assessed as CFU per whole stomach.

Serology
--------

Anti-*H. pylori* IgG values in sera from gerbils were determined by ELISA developed in our laboratory [@B4],[@B24]. The reference serum, which was pooled from sera of anti-*H. pylori* IgG-positive gerbils, was diluted serially from 1:100 to 1:3,200 with PBS (pH 7.4) containing 4% bovine serum albumin, and the amount of anti-*H. pylori* IgG corresponding to a 1:3,200 dilution was expressed as a reference value of a 1.0 arbitrary index (AI). Microwell strips coated with *H. pylori* antigens from a GAP-IgG kit (Biomerica, Newport Beach, Calif.) were used. The antigens in the GAP-IgG kit were acid extracts of organisms derived from the *H. pylori* ATCC 43504 strain. Aliquots of 100 µl of reference serum or 1:200 of diluted serum were added to the wells, and the plates were incubated for 1 h at room temperature. After washing was done, 100 µl of HRP-conjugated anti-gerbil IgG (diluted 1:1,500 in PBS containing 0.05% Tween 20 \[PBS-T\]) was added, and the plates were incubated for 30 min at room temperature. The plates were washed and incubated with 100 µl of substrate (0.35 mg of 3,3\',5,5\'-tetramethylbenzidine per ml and 0.15 mg of H~2~O~2~ per ml) for 10 min. After stopping the reaction with 1 N HCl, the color was read at 450 nm. The serum anti-*H. pylori* IgG value was determined from a standard curve of calibrators.

Histopathological analyses
--------------------------

The excised stomachs (half) were fixed in 20 % phosphate-buffered formalin for 24 hours at 4℃ and then were cut along the longitudinal axis into five strips, which were then embedded in paraffin. Tissue sections were stained with hematoxylin and eosin (HE) for morphological observations, and with alcian blue (pH 2.5)-periodic acid Schiff (PAS) for the detection of mucin-containing cells. Because the inflammatory component of the mucosa was virtually identical to that found in human *H. pylori* gastritis, the degree of inflammation could be graded according to the Updated Sydney System (visual analogue scale: normal, 0; mild,1; moderate, 2; marked, 3) [@B25]. The mucosal thickness was measured at ten different arbitrarily selected points in the mid-antrum and mid-body. In addition, tissue sections were immunostained for *H. pylori* (rabbit polyclonal anti-*H. pylori* antibody, 1:20; DAKO, Kyoto, Japan), using an indirect immunoperoxidase method (peroxidase-labeled goat anti-mouse Ig antibody, 1:50, DAKO; peroxidase-labeled goat anti-rabbit Ig antibody, 1:50, DAKO).

The BrdU labeling was visualized using mouse monoclonal anti-BrdU antibody (1:50, DAKO), as described previously [@B4]. The labeling index was calculated by expressing the number of BrdU-positive epithelial cells as a percentage of the total number of epithelial cells from 10 different points, which were arbitrary selected, in the lesser curvature of the mid-antrum.

Statistical analyses
--------------------

The statistical significance of the incidence of positive bacterial culture was evaluated using Fisher\'s exact test; the other factors were assessed by Student\'s t test after an analysis of variance. *P* values of less than 0.05 were considered to indicate significant differences. The results are expressed as the mean±standard deviation.

3. Results
==========

Bacteriological and serological findings
----------------------------------------

In group A (*H. pylori* inoculation followed by JRF treatment), bacterial culture was positive in 5 of 20 gerbils (25 %) and then the density of *H. pylori* colonization was (3.8±2.3) X 10^2^ CFU/stomach. Both of the incidence and density were significantly less than that in group B (*H. pylori* inoculation without JRF treatment. 84 % and (8.6±9.9) x 10^4^ CFU/stomach, respectively). The titers of anti-*H. pylori* antibodies in group A was less than that in group B, however, the difference did not reach statistical significance at the time of sacrifice. (Table [1](#T1){ref-type="table"})

Histopathological findings
--------------------------

In animals from non-*H. pylori* inoculated groups (C and D), inflammatory cell infiltration into the lamina propria was negligible (Table [1](#T1){ref-type="table"} and Fig [2](#F2){ref-type="fig"}C). In contrast, active gastritis developed in the gastric mucosa of gerbils in group B (*H. pylori* inoculation only), which thus showed a marked mucosal infiltration of inflammatory cells (Table [1](#T1){ref-type="table"} and Fig [2](#F2){ref-type="fig"}B). In addition, superficial erosions in the antrum and irregularity of the pyloric glands were frequently observed in group B (Fig [2](#F2){ref-type="fig"}B). However, the degree of mucosal infiltration of inflammatory cells (both of neutrophilic polymorphonuclear and mononuclear cells) in group A (*H. pylori* inoculation followed by JRF treatment) was significantly less than that in group B (Table [1](#T1){ref-type="table"} and Fig [2](#F2){ref-type="fig"}A). In addition, no intestinal metaplasia or tumors in the gastric mucosa were observed in any groups based on the findings of this experiment.

In addition to serological and bacteriological studies, the degree of infection of*H. pylori* was investigated by immunostainging. In group B, many *H. pylori* bacteria were detected on the surface of the mucosa (Fig [3](#F3){ref-type="fig"}B). On the other hand, only a small number of bacteria were found to exist in group A (Fig [3](#F3){ref-type="fig"}A).

The extent of epithelial proliferation was evaluated based on the BrdU labeling index. The BrdU labeling index in group A decreased significantly more than that in group B (Table [1](#T1){ref-type="table"}), although it increased than in the non-*H. pylori* controls (groups C and D).

4. Discussion
=============

In the present study, we showed the suppressive effect of Japanese rice-fluid (JRF) on *H. pylori* infection in the Mongolian gerbil model. Both cultures and immunostaining of the stomach demonstrated a clear reduction in the *H. pylori* colonization. It is natural that the difference of anti-*H. pylori* antibody titers was not so large between the JRF -treated gerbils and the non-treated ones at the time of sacrifice, since several months are usually needed to show a significant decrease in the antibody titers after the eradication of *H. pylori* from the stomach [@B26]. In addition to the suppressive effect of *H. pylori* infection, JRF reduced mucosal inflammation and epithelial proliferation in the stomach of *H. pylori*-infected gerbils. It is likely that *H. pylori*-eradication caused a decrease in the degree of inflammation in the stomach, although there is a possibility that JRF itself has an anti-inflammatory effect on the gastric mucosa.

A positive association between a high rice intake and atrophic gastritis has been reported in some epidemiological studies [@B27]. However, the direct effect of rice on the promotion of atrophic gastritis is still unclear. There is a possibility that rice intake is only a marker of other dietary factors such as salt or ethnic/social factors. Therefore, it is not surprising that a substance produced from rice, namely JRF, showed both an anti*-H.pylori* and anti-inflammation effect on the stomachs infected with *H. pylori*. In addition, JRF also has completely different activity from rice itself: in our *in vitro* experiment, rice itself did not show any anti-*H.pylori*activity, while JRF showed a strong bactericidal activity against *H. pylori* [@B23].

Even though the triple therapy, using two antibacterial antibiotics and a proton pump inhibitor, is effective and its short duration helps maintain patient compliance, a considerable number of patients experience undesirable side-effects, such as diarrhea, epigastric pain, nausea and bloating [@B28]. Contrary to this, JRF is considered to demonstrate relatively few side-effects, since rice is eaten as a staple diet in most Eastern countries, including Japan. In addition, in the *in vitro* experiment, the antibacterial spectrum of JRF was found to be extremely narrow and it was only found to be active against some restricted organisms including *H. pylori*, however, it did not demonstrate any antibacterial activity against *Escherichia coli*, *Klebsiella pneumoniae*, *K. oxytoca*, or *Enterococcus faecalis*, which are all representative well known normal inhabitants of the human intestinal flora [@B23].

These safety characteristics of JRF may be therefore appropriate for the use in prevention of *H. pylori* infection. As chronic inflammation and increased cell proliferation are features common to the pathogenesis of many human cancers, and as these features seem to play a central role in the initiation and promotion of carcinogenesis, the suppression of inflammation and cell proliferation by JRF may thus be an effective modality for preventing *H. pylori*-induced carcinogenesis in the stomach.

In our previous study, a Rice Power Extract (RPE) showed a suppressive effect of gastric mucosal inflammation, but it did not show significant decrease in the viable *H. pylori* obtained from stomach samples [@B22]. In contrast, JRF showed a significant reduction of both *H. pylori* colonization and mucosal inflammation in the stomach. Although both of JRF and RPE are made from rice, their constituents could differe somewhat between them, since the manufacturing method is completely different: JRF is manufactured by incubation at high temperatures under high pressure and treatment with proteinase-amylase complex, while RPE is prepared by saccharization using *Aspergillus oryzae* and fermentation using *Saccharomyces cerevisiae* [@B22]. These manufacturing processes could therefore cause the differences observed in the anti-*H. pylori* activity between JRF and RPE. However, the mechanism of anti-*H. pylori* activity in JRF still remains to be elucidated. This mechanism of action should be clarified in future studies, and then the anti-*H. pylori* effect should thereafter be confirmed in human trials.

![Experimental protocol. HP: Inoculation of *Helicobacter pylori*. w: weeks. The rice-fluid (RF) was given ad libitum from 9 weeks of age to the end of the experiment. All gerbils were sacrificed 14 weeks after inoculation of HP (21 weeks of age).](ijmsv04p0203g01){#F1}

![Histology of pyloric mucosa. H & E, X 40. (A) pyloric mucosa of Mongolian gerbil that was inoculated with *H. pylori* at 7 weeks of age and given rice-fluid from 2 weeks until 14 weeks after *H. pylori*inoculation (group A), (B) pyloric mucosa of Mongolian gerbil inoculated with *H. pylori* and given distilled water (group B), (C) normal (control) pyloric mucosa (group D). The degree of mucosal infiltration of inflammatory cells in group A (JRF treatment(+)) (asterisks) was less than that in group B (JRF treatment(-))(asterisks).](ijmsv04p0203g02){#F2}

![Immunostaining for *H. pylori*, X 80. (A) inoculation with *H. pylori* with treatment of rice-fluid, (B) inoculation with *H. pylori* without treatment of rice-fluid. Many *H. pylori* bacteria were detected on the surface of the mucosa in group B (JRF treatment(-)), while only a small number of bacteria were found to exist in group A (JRF treatment(+)).](ijmsv04p0203g03){#F3}

###### 

Summary of the experiment. HP: Inoculation of *Helicobacter pylori*. mono: mononuclear cells. F/T: the ratio of fundic mucosa to total glandular stomach length. \*: statistically significant compared with group B (P\<0.01).

                             Bacterial culture                    Antibod Y titers (AI)   Infiltration of               Mucosal thiskness                           BrdU Labeling index
  ------- ----- ------------ ------------------- ---------------- ----------------------- ----------------- ----------- ------------------- ------------- --------- ---------------------
  group   HP    Rice fluid   Incidence (%)       Density 100CFU                           neutrophils       mono        Antrum (mm)         Corpus (mm)   F/T (%)   
  A       (+)   (+)          25\*                3.8±2.3          50±60                   2.3±0.5\*         1.2±0.4\*   0.35±0.1            1.2±0.3       43±6      4.0±0.2\*
  B       (+)   (-)          84                  860±990          78±70                   2.9±0.3           2.5±0.5     0.39±0.1            1.2±0.1       38±15     6.4±0.7
  C       (-)   (+)          \-                  \-               \-                      0                 0           0.19±0.01           0.61±0.1      81±4      0.9±0.2
  D       (-)   (-)          \-                  \-               \-                      0                 0           0.20±0.02           0.62±0.1      82±5      0.9±0.1
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